Epilepsy Foundation   Report issue

Foundation Phase 4
Founded: Landover MD United States (1968)

Organization Overview

First Clinical Trial
2008
NCT00835627
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now